Clinical appearance of neuroblastoma 10 years after screening
- 13 March 2006
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 49 (7) , 1012-1014
Abstract
A follow-up study was performed for children with previous repeated positive results by neuroblastoma mass screening and negative clinical results (30 out of 439,128 children screened in Austria between 1991 and 2003, median follow-up 113 months). Four children had continuously elevated urine catecholamines for more than 6 months. One of these patients was diagnosed with pelvic neuroblastoma and multiple metastases 10 years after the first positive screening result. In the light of a 'wait and see' strategy for localized neuroblastomas, our observation suggests that these patients should be further observed even after normalization of urine catecholamines.Keywords
Funding Information
- Styrian Government
- Styrian Children's Cancer Fund
- Children's Cancer Research Institute, Vienna
This publication has 19 references indexed in Scilit:
- “Wait and see” strategy in localized neuroblastoma in infants: An option not only for cases detected by mass screeningPediatric Blood & Cancer, 2004
- A Halt to Neuroblastoma Screening in JapanNew England Journal of Medicine, 2004
- Neuroblastoma Mass Screening in Late Infancy: Insights Into the Biology of Neuroblastic TumorsJournal of Clinical Oncology, 2003
- MYCN gain and MYCN amplification in a stage 4S neuroblastomaCancer Genetics and Cytogenetics, 2003
- Neuroblastoma Screening at One Year of AgeNew England Journal of Medicine, 2002
- Survival of children with neuroblastomaEuropean Journal of Cancer, 2001
- Past and Future of Neuroblastoma Screening in JapanJournal of Pediatric Hematology/Oncology, 1992
- International variations in the incidence of neuroblastomaInternational Journal of Cancer, 1992
- Do children benefit from mass screening for neuroblastoma?The Lancet, 1991
- Effects of the mass screening of neuroblastoma in sapporo cityCancer, 1987